What Is Medical Affairs? A Complete Guide to the Third Pillar of Pharma

If you're asking "what is medical affairs" because you've seen the term on a job posting, an org chart, or a LinkedIn title and are not quite sure where it fits, here's the short version:

Medical Affairs is the function within a pharmaceutical, biotech, or medical device company responsible for the scientific and clinical communication between a company and the healthcare community, operating as a non-promotional scientific function with appropriate independence from Commercial activities.  It exists to generate, interpret, and share clinical evidence; answer unsolicited medical questions from physicians; support clinical research; and represent the scientific voice of the company both internally and externally.

Medical Affairs sits alongside Commercial and Research & Development (R&D) as what the industry increasingly calls pharma's "third pillar." Where Commercial focuses on approved product promotion and business objectives and R&D focuses on developing the product, Medical Affairs focuses on the evidence and the science, before, during, and long after a product launches.

Why Medical Affairs Exists as a Separate Function

The distinction is rooted in the different scientific, regulatory, and business responsibilities of Medical Affairs and Commercial teams. Promotional communications must comply with applicable regulatory requirements, and inappropriate promotion of unapproved uses can create regulatory and legal risks.

But physicians and researchers do have off-label questions, complex clinical inquiries, and interest in ongoing trial data that a sales conversation legally cannot touch. Medical Affairs helps address these scientific information needs through compliant, non-promotional scientific exchange.

That independence is not a technicality. Scientific independence, transparency, and evidence-based communication are essential to maintaining credibility with healthcare professionals: a Medical Science Liaison or Medical Information specialist is not trying to hit a sales quota, so what they say carries a different kind of trust.

The Core Functions Inside Medical Affairs

"Medical Affairs" is not one job, it's an umbrella covering several distinct roles that work together across a product's lifecycle:

Medical Science Liaisons (MSLs) The field-based arm of Medical Affairs. MSLs build relationships with Key Opinion Leaders (KOLs), engage in scientific exchange through in-person and virtual interactions, and bring field insights back to the company. Read our full breakdown of the MSL role here.

Medical Information The team that responds to unsolicited medical inquiries, from physicians, patients, or internal stakeholders, with accurate, referenced, non promotional answers, often through a call center or written response function.

Health Economics and Outcomes Research (HEOR) Builds the economic and real world evidence case for a product, increasingly critical as payers demand outcomes data, not just clinical trial results, to justify reimbursement.

Publications and Medical Writing Manages the scientific publication strategy, abstracts, manuscripts, and conference presentations, ensuring data is shared with the medical community in a compliant, properly authored way.

Medical Education and Advisory Boards Coordinates continuing medical education (CME) support and advisory board meetings, where a company gathers structured input from external experts on unmet need, trial design, or emerging data.

At smaller biotech and pre commercial companies, several of these functions often collapse into one or two people wearing multiple hats, a Medical Affairs "team of one" is not unusual pre launch.

What Is Medical Affairs' Role in Pharma, Across the Product Lifecycle?

Medical Affairs is not just a post launch support function, its role shifts at every stage:

• Early development: Providing scientific and clinical input into trial design, identifying unmet medical need, and beginning early KOL relationship building well before a product is approved.
• Pre-launch: Preparing the scientific narrative, training internal teams on the data, and supporting appropriate pre-launch scientific exchange about available clinical evidence.
• Launch: Supporting the initial rollout with scientific exchange, addressing physician questions the label alone cannot answer, and gathering early real world feedback.
• Post-launch: Generating real world evidence, supporting label expansions, responding to emerging safety or efficacy questions, and maintaining ongoing KOL relationships as the competitive and scientific landscape evolves.

This lifecycle spanning role is exactly why Medical Affairs has moved from what used to be a purely post approval, support oriented function into something companies increasingly involved during earlier stages of clinical development.

Medical Affairs in Pharma: Why the Function Is Growing

A few converging forces are pushing Medical Affairs further into a strategic leadership role rather than a support one:

• Scientifically complex launches. Biologics, cell and gene therapies, and precision medicine require far more nuanced physician education than a traditional small-molecule drug ever did.
• Compressed evidence timelines. Regulatory and pricing pressure (including IRA-driven timelines in the U.S.) is pushing companies to generate real world evidence faster which depends heavily on Medical Affairs infrastructure.
• Reduced commercial access to physicians. As physicians spend less time with sales representatives, the scientific, trust based relationship an MSL or medical director can offer becomes more valuable, not less.
• Standardization and certification. As the function scales, professional organizations continue to develop competency frameworks and educational resources to support Medical Affairs professionals.

The practical result: Medical Affairs is increasingly recognized for its strategic contributions to clinical development and product lifecycle management, and it's increasingly common for Medical Affairs leadership to sit at the same strategic table as Commercial and R&D, not several steps behind them.

Medical Affairs vs. Commercial vs. R&D, What's the Actual Difference?

The clearest way to think about it: R&D investigates product safety and efficacy through preclinical and clinical research. Medical Affairs explains why and for whom, using non-promotional scientific channels. Commercial drives adoption within the boundaries of what's been proven and approved. Medical Affairs facilitates appropriate, compliant, non-promotional scientific exchange, including responses to unsolicited questions about unapproved uses.

Career Paths in Medical Affairs

Medical Affairs offers one of the more structured, if competitive, career paths in the life sciences industry. One possible field medical career progression looks like this, although titles and pathways vary by organization:

1. Associate MSL / MSL, the most common entry point, usually requiring an advanced clinical or scientific degree (PharmD, PhD, MD, NP)
2. Senior MSL / Medical Affairs Scientist, increased autonomy, more complex therapeutic areas, mentoring junior team members
3. MSL Manager / Field Director, people leadership, territory strategy, cross-functional planning
4. Director / Senior Director of Medical Affairs, strategic ownership of a therapeutic area or product's entire medical strategy
5. VP / Head of Medical Affairs, executive leadership spanning the Medical Affairs function

Professionals also move laterally between MSL work and the other Medical Affairs functions, Medical Information, HEOR, or Publications, depending on whether they prefer field based relationship work or office based strategic and analytical work.

FAQ: Medical Affairs Basics

1 - What is medical affairs in simple terms? 

It's the department in a pharmaceutical or biotech company responsible for scientific and clinical communication with the medical community, separate from sales and marketing, and focused on evidence rather than promotion. It is a non-promotional function that maintains appropriate independence from Commercial activities while collaborating cross-functionally. 

2 - What does Medical Affairs do in a pharmaceutical company? 

"Medical affairs pharma" typically refers to the same function as it exists within pharmaceutical (as opposed to device or diagnostics) companies, the terms are used interchangeably in most job postings and industry discussion.

3 - Is medical affairs the same as an MSL? 

No, an MSL (Medical Science Liaison) is one specific, field-based role within Medical Affairs. Medical Affairs also includes Medical Information, HEOR, Publications, and Medical Education functions. See our full guide to the MSL role.

4 - Why is medical affairs considered pharma's "third pillar"? 

Because it now operates as a strategic function alongside Commercial and R&D, rather than reporting into either, with its own budget, leadership, and influence over how a product's scientific story is developed and shared.

5 - How do you get into medical affairs? 

Entry requirements vary by function, and professionals can enter Medical Affairs through field medical, Medical Information, publications, medical writing, and other scientific roles.

Considering a move into Medical Affairs, or looking to grow within it? Explore Excel Into MSL™ to start your path in, or Excel As An MSL™ if you're already in the field and ready for what's next.